DE602005009707D1 - Metallkomplexierte phospholderivate und pharmazeutische verwendungen dafür - Google Patents

Metallkomplexierte phospholderivate und pharmazeutische verwendungen dafür

Info

Publication number
DE602005009707D1
DE602005009707D1 DE602005009707T DE602005009707T DE602005009707D1 DE 602005009707 D1 DE602005009707 D1 DE 602005009707D1 DE 602005009707 T DE602005009707 T DE 602005009707T DE 602005009707 T DE602005009707 T DE 602005009707T DE 602005009707 D1 DE602005009707 D1 DE 602005009707D1
Authority
DE
Germany
Prior art keywords
phosphol
complexed
derivatives
metal
pharmaceutical uses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005009707T
Other languages
English (en)
Inventor
Katja Becker-Brandenburg
Elisabeth Davioud-Charvet
Valerie Deborde
Regis Reau
R Heiner Schirmer
Christel Herold-Mende
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Publication of DE602005009707D1 publication Critical patent/DE602005009707D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • AIDS & HIV (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
DE602005009707T 2004-07-30 2005-07-29 Metallkomplexierte phospholderivate und pharmazeutische verwendungen dafür Active DE602005009707D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0408427A FR2873586B1 (fr) 2004-07-30 2004-07-30 Derives phospholes complexes a des metaux, et leurs utilisations pharmaceutiques
PCT/FR2005/002004 WO2006024770A2 (fr) 2004-07-30 2005-07-29 Derives phospholes complexes a des metaux, et leurs utlisations pharmaceutiques

Publications (1)

Publication Number Publication Date
DE602005009707D1 true DE602005009707D1 (de) 2008-10-23

Family

ID=34947254

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005009707T Active DE602005009707D1 (de) 2004-07-30 2005-07-29 Metallkomplexierte phospholderivate und pharmazeutische verwendungen dafür

Country Status (8)

Country Link
US (1) US7923434B2 (de)
EP (1) EP1771181B1 (de)
AT (1) ATE407681T1 (de)
CA (1) CA2576781C (de)
DE (1) DE602005009707D1 (de)
ES (1) ES2317310T3 (de)
FR (1) FR2873586B1 (de)
WO (1) WO2006024770A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2904474B1 (fr) * 2006-07-27 2008-10-24 Commissariat Energie Atomique Diodes organiques electroluminescentes blanches a base de molecules derivees du phosphole
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
WO2022079085A1 (en) 2020-10-13 2022-04-21 Heidelberg University Phosphaphenalene-gold(i) complexes as chemotherapeutic agents against glioblastoma

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001077121A1 (en) * 2000-04-10 2001-10-18 National University Of Singapore Gold complexes

Also Published As

Publication number Publication date
FR2873586A1 (fr) 2006-02-03
WO2006024770A2 (fr) 2006-03-09
US7923434B2 (en) 2011-04-12
US20080045465A1 (en) 2008-02-21
CA2576781C (fr) 2013-12-24
CA2576781A1 (fr) 2006-03-09
ES2317310T3 (es) 2009-04-16
EP1771181B1 (de) 2008-09-10
WO2006024770A8 (fr) 2007-05-03
EP1771181A2 (de) 2007-04-11
WO2006024770A3 (fr) 2006-04-13
ATE407681T1 (de) 2008-09-15
FR2873586B1 (fr) 2006-10-27

Similar Documents

Publication Publication Date Title
ATE467413T1 (de) Oxindolderivate als antikrebsmittel
TW200642689A (en) Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient
SG154433A1 (en) Phthalazine derivatives as parp inhibitors
UA94065C2 (en) Dihydropseudoerythromycin derivatives
TW200700393A (en) Novel cis-2,4,5-triaryl-imidazolines
TNSN06411A1 (en) Pyrimidine urea derivatives as kinase inhibitors
BR0312573A (pt) Derivados de fenil-[4-(3-fenil-1h-pirazol-4-il)-pirimidin-2-il]-amina
BRPI0513149A (pt) uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas substituìdas no tratamento de náuseas e vÈmito
DE602006020295D1 (de) Azabenzimidalzolderivate, ihre herstellung und ihre verwendung als antikrebsmittel
MX2008002492A (es) Composiciones farmaceuticas que comprenden un farmaco dependiente del ph, un modificador del ph, y un agente retardante.
ATE428411T1 (de) Hdl-verstärkende kombinationstherapie-komplexe
ATE420639T1 (de) Antimykotische mittel
EA200800927A1 (ru) КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
WO2007120333A3 (en) Tetracyclic kinase inhibitors
TW200730513A (en) Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases
IL178727A (en) Tetrahydropyridothiophene derivatives and pharmaceutical compositions containing the same
TW200704409A (en) Stabilized pharmaceutical and cosmetic composition of catechins or derivatives thereof
BR0313385A (pt) Derivados de pirimidina-2,4-diona como inibidores de metaloproteinase da matriz
SG151306A1 (en) Novel benzothiazoles and the use thereof as medicaments
UA87312C2 (ru) КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ
MX2007004274A (es) Quinazolinilmetilentiazolinonas como inhibidores de cdk1.
BRPI0615141A2 (pt) inibidores pentacìclicos de quinase
TW200744612A (en) New combination
MY146444A (en) Benzooxazol-2-one derivatives as inhibitors of lipases and phospholipases

Legal Events

Date Code Title Description
8364 No opposition during term of opposition